323 related articles for article (PubMed ID: 7927774)
21. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.
Escudero R; Halluska ML; Backenson PB; Coleman JL; Benach JL
Infect Immun; 1997 May; 65(5):1908-15. PubMed ID: 9125579
[TBL] [Abstract][Full Text] [Related]
23. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
Liang FT; Caimano MJ; Radolf JD; Fikrig E
Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
[TBL] [Abstract][Full Text] [Related]
24. Identification of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii in Ixodes ricinus ticks from southern Bohemia using monoclonal antibodies.
Stĕpánová-Tresová G; Kopecký J; Kuthejlová M
Zentralbl Bakteriol; 2000 Jan; 289(8):797-806. PubMed ID: 10705611
[TBL] [Abstract][Full Text] [Related]
25. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
[TBL] [Abstract][Full Text] [Related]
26. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Izac JR; Oliver LD; Earnhart CG; Marconi RT
Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
[TBL] [Abstract][Full Text] [Related]
27. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
Ma Y; Weis JJ
Infect Immun; 1993 Sep; 61(9):3843-53. PubMed ID: 8359905
[TBL] [Abstract][Full Text] [Related]
28. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
[TBL] [Abstract][Full Text] [Related]
29. OspB antibody prevents Borrelia burgdorferi colonization of Ixodes scapularis.
Fikrig E; Pal U; Chen M; Anderson JF; Flavell RA
Infect Immun; 2004 Mar; 72(3):1755-9. PubMed ID: 14977984
[TBL] [Abstract][Full Text] [Related]
30. Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi.
Tilly K; Bestor A; Rosa PA
Infect Immun; 2016 May; 84(5):1565-1573. PubMed ID: 26953324
[TBL] [Abstract][Full Text] [Related]
31. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
[TBL] [Abstract][Full Text] [Related]
32. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks.
de Silva AM; Fish D; Burkot TR; Zhang Y; Fikrig E
Infect Immun; 1997 Aug; 65(8):3146-50. PubMed ID: 9234767
[TBL] [Abstract][Full Text] [Related]
33. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
Cassatt DR; Patel NK; Ulbrandt ND; Hanson MS
Infect Immun; 1998 Nov; 66(11):5379-87. PubMed ID: 9784547
[TBL] [Abstract][Full Text] [Related]
34. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
Gipson CL; de Silva AM
Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
[TBL] [Abstract][Full Text] [Related]
35. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
Probert WS; LeFebvre RB
Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
[TBL] [Abstract][Full Text] [Related]
36. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
37. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells.
Comstock LE; Fikrig E; Shoberg RJ; Flavell RA; Thomas DD
Infect Immun; 1993 Feb; 61(2):423-31. PubMed ID: 7678585
[TBL] [Abstract][Full Text] [Related]
39. A new approach to a Lyme disease vaccine.
Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
[TBL] [Abstract][Full Text] [Related]
40. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
Johnson BJ; Sviat SL; Happ CM; Dunn JJ; Frantz JC; Mayer LW; Piesman J
Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
